$IVST Grows Revenue to $40.2 Million in 2019, Engages BDO USA LLP as Auditor in Advance of SEC Registration and Uplisting Initiatives
CLEVELAND, OH / ACCESSWIRE / May 18, 2020 / Innovest Global, Inc. (OTC PINK:IVST), a diversified industrials company, today announced results for the fiscal year ended December 31, 2019.
Key Fourth Quarter 2019 and Subsequent Operational Highlights
Completed the acquisition of a 100% interest in StemVax Therapeutics, a biotechnology company developing novel therapies for brain tumor patients, which will be a stand-alone public company once spun out from Innovest Global in mid-2020.
Identified four additional acquisition targets, with letters of intent signed for three of the four targets, which together represent over $35 million in revenue and $5 million in net income.
Filed a Form 10 Registration Statement with the U.S. Securities and Exchange Commission (SEC) to become a fully reporting company, subject to quarterly, annual and other reporting documents.
Appointed BDO USA, LLP on May 14, 2020 as the Company's independent registered public accounting firm.
Engaged MZ Group to lead a comprehensive strategic investor relations and financial communications program across all key markets.
